Long-term response of different Botulinum toxins in refractory neurogenic detrusor overactivity due to spinal cord injury

ABSTRACT Purpose To assess the response in spinal cord injured patients alternatively treated with different types and dosages of Botulinum neurotoxin type A (BoNT/A) over 15 years. Material and methods Patients who underwent first BoNT/A from 1999-2001 and practiced intermittent catheterization...

Full description

Bibliographic Details
Main Authors: Giuseppe Lombardi, Stefania Musco, Giovanni Bacci, Maria Celso, Valerio Bellio, Giulio Del Popolo
Format: Article
Language:English
Published: Sociedade Brasileira de Urologia
Series:International Brazilian Journal of Urology
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382017000400721&lng=en&tlng=en
_version_ 1811218513328603136
author Giuseppe Lombardi
Stefania Musco
Giovanni Bacci
Maria Celso
Valerio Bellio
Giulio Del Popolo
author_facet Giuseppe Lombardi
Stefania Musco
Giovanni Bacci
Maria Celso
Valerio Bellio
Giulio Del Popolo
author_sort Giuseppe Lombardi
collection DOAJ
description ABSTRACT Purpose To assess the response in spinal cord injured patients alternatively treated with different types and dosages of Botulinum neurotoxin type A (BoNT/A) over 15 years. Material and methods Patients who underwent first BoNT/A from 1999-2001 and practiced intermittent catheterization were included. Baseline 3-day bladder diary (BD) and urodynamics were collected. BoNT/A failure was defined when patients asked for re-injection ≤ 3 months post-treatment. Criteria for re-injection was at least one daily episode of urinary incontinence at BD. Before re-injection, patients were asked if they had reached 6 months of dryness without antimuscarinics (YES response). Results Overall, 32/60 (53.4%) “No failure” (NF) group; 16 (26.6%) “occasional failure” (OF) and 12 (20%) “consecutive failure” (CF) were included. A total of 822 BoNT/A infiltrations were performed. The mean interval from previous injection to treatment re-scheduling was 8 months. No significant differences between treatments were found within the three groups (p>0.05). The percentage of YES responses increased from 19% (AboBoNT/A 500IU) to 29 % (OnaBoNT/A 300IU) in NF, and from 18% (AboBoNT/A 500IU) to 25% (OnaBoNT/A 300IU) for OF. Five NF cases (15.6%) maintained 6 months of dryness after each injection. Among the baseline variables, only low compliance (< 20mL/cmH2O) was found as predictor for failure (p=0.006). Conclusions Long term BoNT/A for NDO did not increase failures, independent of the types of treatments and switching. Definition of failure and other criteria for continuing repetitive BoNT/A treatment is mandatory. CF was predictable for no response in earlier follow-up.
first_indexed 2024-04-12T07:11:07Z
format Article
id doaj.art-d9474c3b14304b19bbad9899a56ea437
institution Directory Open Access Journal
issn 1677-6119
language English
last_indexed 2024-04-12T07:11:07Z
publisher Sociedade Brasileira de Urologia
record_format Article
series International Brazilian Journal of Urology
spelling doaj.art-d9474c3b14304b19bbad9899a56ea4372022-12-22T03:42:39ZengSociedade Brasileira de UrologiaInternational Brazilian Journal of Urology1677-611943472172910.1590/s1677-5538.ibju.2016.0584S1677-55382017000400721Long-term response of different Botulinum toxins in refractory neurogenic detrusor overactivity due to spinal cord injuryGiuseppe LombardiStefania MuscoGiovanni BacciMaria CelsoValerio BellioGiulio Del PopoloABSTRACT Purpose To assess the response in spinal cord injured patients alternatively treated with different types and dosages of Botulinum neurotoxin type A (BoNT/A) over 15 years. Material and methods Patients who underwent first BoNT/A from 1999-2001 and practiced intermittent catheterization were included. Baseline 3-day bladder diary (BD) and urodynamics were collected. BoNT/A failure was defined when patients asked for re-injection ≤ 3 months post-treatment. Criteria for re-injection was at least one daily episode of urinary incontinence at BD. Before re-injection, patients were asked if they had reached 6 months of dryness without antimuscarinics (YES response). Results Overall, 32/60 (53.4%) “No failure” (NF) group; 16 (26.6%) “occasional failure” (OF) and 12 (20%) “consecutive failure” (CF) were included. A total of 822 BoNT/A infiltrations were performed. The mean interval from previous injection to treatment re-scheduling was 8 months. No significant differences between treatments were found within the three groups (p>0.05). The percentage of YES responses increased from 19% (AboBoNT/A 500IU) to 29 % (OnaBoNT/A 300IU) in NF, and from 18% (AboBoNT/A 500IU) to 25% (OnaBoNT/A 300IU) for OF. Five NF cases (15.6%) maintained 6 months of dryness after each injection. Among the baseline variables, only low compliance (< 20mL/cmH2O) was found as predictor for failure (p=0.006). Conclusions Long term BoNT/A for NDO did not increase failures, independent of the types of treatments and switching. Definition of failure and other criteria for continuing repetitive BoNT/A treatment is mandatory. CF was predictable for no response in earlier follow-up.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382017000400721&lng=en&tlng=enBotulinum Toxins, Type ASpinal Cord CompressionUrinary Bladder, Neurogenic
spellingShingle Giuseppe Lombardi
Stefania Musco
Giovanni Bacci
Maria Celso
Valerio Bellio
Giulio Del Popolo
Long-term response of different Botulinum toxins in refractory neurogenic detrusor overactivity due to spinal cord injury
International Brazilian Journal of Urology
Botulinum Toxins, Type A
Spinal Cord Compression
Urinary Bladder, Neurogenic
title Long-term response of different Botulinum toxins in refractory neurogenic detrusor overactivity due to spinal cord injury
title_full Long-term response of different Botulinum toxins in refractory neurogenic detrusor overactivity due to spinal cord injury
title_fullStr Long-term response of different Botulinum toxins in refractory neurogenic detrusor overactivity due to spinal cord injury
title_full_unstemmed Long-term response of different Botulinum toxins in refractory neurogenic detrusor overactivity due to spinal cord injury
title_short Long-term response of different Botulinum toxins in refractory neurogenic detrusor overactivity due to spinal cord injury
title_sort long term response of different botulinum toxins in refractory neurogenic detrusor overactivity due to spinal cord injury
topic Botulinum Toxins, Type A
Spinal Cord Compression
Urinary Bladder, Neurogenic
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382017000400721&lng=en&tlng=en
work_keys_str_mv AT giuseppelombardi longtermresponseofdifferentbotulinumtoxinsinrefractoryneurogenicdetrusoroveractivityduetospinalcordinjury
AT stefaniamusco longtermresponseofdifferentbotulinumtoxinsinrefractoryneurogenicdetrusoroveractivityduetospinalcordinjury
AT giovannibacci longtermresponseofdifferentbotulinumtoxinsinrefractoryneurogenicdetrusoroveractivityduetospinalcordinjury
AT mariacelso longtermresponseofdifferentbotulinumtoxinsinrefractoryneurogenicdetrusoroveractivityduetospinalcordinjury
AT valeriobellio longtermresponseofdifferentbotulinumtoxinsinrefractoryneurogenicdetrusoroveractivityduetospinalcordinjury
AT giuliodelpopolo longtermresponseofdifferentbotulinumtoxinsinrefractoryneurogenicdetrusoroveractivityduetospinalcordinjury